Exploration of Binding Affinities of a 3β,6β-Diacetoxy-5α-cholestan-5-ol with Human Serum Albumin: Insights from Synthesis, Characterization, Crystal Structure, Antioxidant and Molecular Docking
Author:
Open Access
Abstract
The present study describes the synthesis, characterization, and in vitro molecular interactions of a steroid 3β,6β-diacetoxy-5α-cholestan-5-ol. Through conventional and solid-state methods, a cholestane derivative was successfully synthesized, and a variety of analytical techniques were employed to confirm its identity, including high-resolution mass spectrometry (HRMS), Fourier transforms infrared (FT-IR), nuclear magnetic resonance (NMR), elemental analysis, and X-ray single-crystal diffraction. Optimizing the geometry of the steroid was undertaken using density functional theory (DFT), and the results showed great concordance with the data from the experiments. Fluorescence spectral methods and ultraviolet–vis absorption titration were employed to study the in vitro molecular interaction of the steroid regarding human serum albumin (HSA). The Stern-Volmer, modified Stern-Volmer, and thermodynamic parameters’ findings showed that steroids had a significant binding affinity to HSA and were further investigated by molecular docking studies to understand the participation of active amino acids in forming non-bonding interactions with steroids. Fluorescence studies have shown that compound 3 interacts with human serum albumin (HSA) through a static quenching mechanism. The binding affinity of compound 3 for HSA was found to be 3.18 × 104 mol−1, and the Gibbs free energy change (ΔG) for the binding reaction was −9.86 kcal mol−1 at 298 K. This indicates that the binding of compound 3 to HSA is thermodynamically favorable. The thermodynamic parameters as well as the binding score obtained from molecular docking at various Sudlow’s sites was −8.2, −8.5, and −8.6 kcal/mol for Sites I, II, and III, respectively, supporting the system’s spontaneity. Aside from its structural properties, the steroid demonstrated noteworthy antioxidant activity, as evidenced by its IC50 value of 58.5 μM, which is comparable to that of ascorbic acid. The findings presented here contribute to a better understanding of the pharmacodynamics of steroids.Keywords
This publication has 65 references indexed in Scilit:
- Cholestane-3β, 5α, 6β-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer CellsPLOS ONE, 2013
- Electrochemical site marker competitive method for probing the binding site and binding mode between bovine serum albumin and alizarin red SElectrochimica Acta, 2011
- Spectroscopic Probing of the Microenvironment in a Protein−Surfactant AssemblyThe Journal of Physical Chemistry B, 2010
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- 6β-Acetamido-5α-hydroxycholestan-3β-yl acetateActa Crystallographica Section E Crystallographic Communications, 2008
- Antioxidant Activity and Total Phenolic Content of Some Brazilian SpeciesPharmaceutical Biology, 2007
- Screening for Antioxidant Activity in Edible Plant Products: Comparison of Low-Density Lipoprotein Oxidation Assay, DPPH Radical Scavenging Assay, and Folin−Ciocalteu AssayJournal of Agricultural and Food Chemistry, 2004
- Development of the Colle-Salvetti correlation-energy formula into a functional of the electron densityPhysical Review B, 1988
- Some Reactions of 3 β-Mesyloxycholestane-5α,6β-diol and Cholest-2-ene-5α,6β-diol AcetatesCanadian Journal of Chemistry, 1973
- ▵5-Cholestene-3β,4β,7α-triol and the Inhibition of the Oxidation of Hydroxyl Groups by Vicinal SubstituentsJournal of the American Chemical Society, 1950